Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
370 studies found for:    Open Studies | "hematopoietic stem cell transplantation"
Show Display Options
Rank Status Study
21 Recruiting Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
Condition: Thalassemia Major
Intervention: Genetic: unrelated CB following haplo-identical hematopoietic stem cells transplantation
22 Recruiting Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
Conditions: Anemia;   Lymphoma;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: erythropoietin;   Drug: iron supplementation
23 Recruiting T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplant;   Poor Marrow Graft Function
Interventions: Procedure: Donor peripheral blood progenitor cells: stimulation, harvesting, isolation and T-cell depletion;   Device: CliniMACS Cell Selection System
24 Recruiting Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation
Condition: HEMATOLOGIC MALIGNANCIES
Intervention: Other: TOTAL LYMPHOID IRRADIATION
25 Recruiting Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
Conditions: Primary Graft Failure;   Secondary Graft Failure
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Hematopoietic stem cell infusion
26 Not yet recruiting Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
Condition: MDS
Intervention: Other: transplantation
27 Recruiting Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Conditions: Leukemia, Myeloid, Acute;   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Procedure: Haploidentical Stem Cell Transplantation
28 Recruiting Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   SCD
Interventions: Drug: Fludarabine;   Procedure: Hematopoietic Stem Cell Transplant (HSCT)
29 Recruiting Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
Condition: Multiple Myeloma
Intervention: Drug: busulfan, melphalan and fludarabine
30 Recruiting Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Conditions: Acute Leukemia;   Newly Diagnosed;   Relapsed
Intervention: Other: assessments
31 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
32 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
Condition: Hematopoietic/Lymphoid Cancer
Interventions: Radiation: Total-Body Irradiation (TBI);   Biological: Donor Lymphocyte Infusion (DLI);   Drug: Cyclophosphamide;   Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT);   Drug: Mycophenolate mofetil
33 Recruiting Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: CMV Infection;   Persistent CMV Viremia
Intervention: Genetic: CMVpp65 Specific T-cells
34 Not yet recruiting Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
Condition: Lymphoma
Interventions: Procedure: Allogeneic stem cell transplantation;   Drug: Fludarabine;   Drug: Thiotepa;   Drug: Methotrexate
35 Recruiting Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
Conditions: Sickle Cell Disease;   Graft Versus Host Disease
Interventions: Drug: Diphenhydramine;   Drug: Acetaminophen;   Drug: Methylprednisolone;   Drug: Meperidine;   Drug: Alemtuzumab;   Drug: Thymoglobulin;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Thiotepa;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Abatacept;   Procedure: Marrow infusion
36 Recruiting Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Leukemia;   Multiple Myeloma;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma
Interventions: Biological: Palifermin;   Biological: Lupron;   Procedure: peripheral blood stem cell transplantation;   Radiation: Total-Body Irradiation (TBI);   Drug: Thiotepa;   Drug: Cyclophosphamide
37 Recruiting HCT Versus CT in Elderly AML
Condition: Acute Myeloid Leukemia
Interventions: Procedure: hematopoietic cell transplantation;   Drug: Non-Transplant treatment approach for consolidation
38 Not yet recruiting Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)
Condition: Combined Immunodeficiencies
Intervention: Biological: Depletion in CD45RA graft donor
39 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies
Condition: Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted
Intervention: Drug: total lymphoid irradiation and anti-thymocyte globulin
40 Not yet recruiting Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Selinexor;   Drug: Melphalan;   Drug: Dexamethasone;   Procedure: Autologous Hematopoietic Cell Transplantation (HCT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.